Abbott Laboratories (ABT) Net Margin Growth (3y) (2012 - 2026)
Abbott Laboratories (ABT) Net Margin Growth (3y) (2012 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | -641.00 |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 459.00 |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | -108.00 |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 941.00 |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | -1,024.00 |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 574.00 |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 216.00 |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 647.00 |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 300.00 |
| 10 | Zimmer Biomet Holdings | 19.32 Bn | 18.91 Bn | 1.54 Bn | -206.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -641.00 |
| Mar 31, 2026 | -388.00 |
| Dec 31, 2025 | 526.00 |
| Sep 30, 2025 | 68.00 |
| Jun 30, 2025 | -196.00 |
| Mar 31, 2025 | -770.00 |
| Dec 31, 2024 | 6,682.00 |
| Sep 30, 2024 | -367.00 |
| Jun 30, 2024 | 97.00 |
| Mar 31, 2024 | -478.00 |
| Dec 31, 2023 | -454.00 |
| Sep 30, 2023 | 31.00 |
| Jun 30, 2023 | 649.00 |
| Mar 31, 2023 | 626.00 |
| Dec 31, 2022 | -232.00 |
| Sep 30, 2022 | 197.00 |
| Jun 30, 2022 | 539.00 |
| Mar 31, 2022 | 1,163.00 |
| Dec 31, 2021 | 892.00 |
| Sep 30, 2021 | 1,183.00 |